SKU | PRO-03-0005036 |
---|---|
Dosage | Tab. |
Brand Name | Cytomis Kit |
Generic | MISOPROSTOL |
Strength | 200 mcg |
Manufacturer | Incepta Pharmaceuticals Ltd. |
Pack | Piece | MRP | ARTO Price |
---|---|---|---|
Single | 1 | 59.14 BDT | 59.14 BDT |
Box | 5 pcs | 295.70 BDT | 295.7 BDT |
Cartoon | X | X | X |
Therapeutic action – Antiprogestogen Indications – Termination of intra-uterine pregnancy, in combination with misoprostol – Induction of labour in the event of intrauterine foetal death, in combination with misoprostol Presentation – 200 mg tablet Dosage and duration – Termination of pregnancy up to 12/14 weeks after the last menstrual period 200 mg as a single dose, followed by a dose of misoprostol 36 to 48 hours later – Induction of labour in the event of intrauterine foetal death 600 mg once daily for 2 days, followed by a dose of misoprostol the 3rd day Contra-indications, adverse effects, precautions – Do not administer to patients with chronic adrenal failure or severe uncontrolled asthma. – May cause: gastrointestinal disturbances, vaginal bleeding, uterine contractions, headache. – Breast-feeding: no contra-indication for a single dose; to be avoided if multiple doses (induction of labour in intrauterine foetal death) Remarks – For labour induction in the event of intrauterine foetal death, mifepristone may sometimes be sufficient to initiate labour but it is often necessary to administer misoprostol. – Do not use mifepristone in ectopic or molar pregnancy. Storage: below 25°C – http://www.inceptapharma.com/product-details.php?pid=24 https://medlineplus.gov/druginfo/meds/a689009.html https://en.wikipedia.org/wiki/Misoprostol